Relations of serum ascorbic acid and α-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey

American Journal of Epidemiology

Volumn 158, Issue 3, 2003, Pages 225-233

  Millen, Amy E ^a   Gruber, Michael ^a   Klein, Ronald ^a   Klein, Barbara E K ^a   Palta, Mari ^a   Mares, Julie A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Ascorbic acid; Diabetic retinopathy; Nutrition surveys; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

DIABETES; HEALTH RISK; NUTRITION; RISK FACTOR;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RACE DIFFERENCE; SMOKING; SUPPLEMENTATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; ALPHA-TOCOPHEROL; ASCORBIC ACID; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIETARY SUPPLEMENTS; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE;

EID: 0042628148     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg116     Document Type: Article

References (45)

1. National Society to Prevent Blindness. Vision problems in the US: prevalence of adult vision impairment. Schaumburg, IL: National Society to Prevent Blindness and Age-related Eye Disease in America, 2002.
2. Van den Enden MK, Nyengaard JR, Ostrow E, et al. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 1995;36:1675-85.
3. Williamson JR, Chang K, Frangos M, et al. Perspectives in diabetes. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993;42:801-13.
4. Cunningham JJ, Mearkle PL, Brown RG. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J Am Coll Nutr 1994;13:344-50.
5. Vinson JA, Staretz ME, Bose P, et al. In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes 1989;38: 1036-41.
6. Wang H, Zhang ZB, Wen RR, et al. Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Res Clin Pract 1995;28:1-8.
7. Yue DK, McLennan S, Fisher E, et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1989;38:257-61.
8. Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999; 22:1245-51.
9. Kunisaki M, Bursell S, Clermont AC, et al. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 1995;269: E239-46.
10. Paolisso G, Maro GD, Galzerano D, et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994;59:1291-6.
11. Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993;16: 1433-7.
12. Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve action in healthy subjects and noninsulin-dependent diabetic patients. Am J Clin Nutr 1993;57: 650-6.
13. Boeing H, Weisgerber UM, Jeckel A, et al. Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 2000;71:1115-22.
14. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes 1992;41:167-73.
15. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39:217-23.
16. Sargeant LA, Wareham NJ, Bingham S, et al. Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer - Norfolk (EPIC - Norfolk) Study. A population-based study. Diabetes Care 2000;23:726-32.
17. Shoff SM, Mares-Perlman JA, Cruickshanks KJ, et al. Glycosylated hemoglobin concentrations and vitamin E, vitamin C, and β-carotene intake in diabetic and nondiabetic older adults. Am J Clin Nutr 1993;58:412-16.
18. Ceriello A, Giugliano D, Quatraro A, et al. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 1991;14:68-72.
19. Jain SK, McVie R, Jaramillo JJ, et al. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type 1 diabetic patients. J Am Coll Nutr 1996;15:458-61.
20. Jain SK, Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 1997;22:593-6.
21. Baynes JW. Perspectives in diabetes: role of oxidative stress in development of complications of diabetes. Diabetes 1991;40: 405-12.
22. Sinclair AJ, Girling AJ, Gray L, et al. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991;34:171-5.
23. Armstrong D, al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med 1991; 11:433-6.
24. Garg MC, Singh KP, Bansal DD. Effect of vitamin E supplementation on antioxidant status of diabetic rats. Med Sci Res 1996;24:325-6.
25. Facchini F, Coulston AM, Reaven GM. Relation between dietary vitamin intake and resistance to insulin-mediated glucose disposal in healthy volunteers. Am J Clin Nutr 1996;63: 946-9.
26. Sanchez-Lugo L, Mayer-Davis EJ, Howard G, et al. Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclersosis Study (IRAS). Am J Clin Nutr 1997;66:1224-31.
27. Skrha J, Sindelka G, Hilgertova J. The effect of fasting and vitamin E on insulin action in obese type 2 diabetes mellitus. Ann N Y Acad Sci 1997;827:556-60.
28. Bishop N, Schorah CJ, Wales JK. The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind, crossover study. Diabet Med 1985;2:121-4.
29. Fuller CJ, Chandalia M, Garg A, et al. RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutr 1996; 63:753-9.
30. Reaven PD, Herold DA, Barnett J, et al. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 1995;18:807-16.
31. Mayer-Davis EJ, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 1998;105:2264-70.
32. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: National Center for Health Statistics, 1994. (Vital and health statistics, series 1: programs and collection procedures, no. 32) (DHHS publication no. (PHS) 94-1308) (GPO no. 017-022-01260-0).
33. World Health Organization. Diabetes mellitus: report of a WHO Study Group. Geneva, Switzerland: World Health Organization, 1985. (Technical Report Series no. 727).
34. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atlanta, GA: National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, 1996.
35. Knekt P, Seppanen R, Aaran R. Determinants of serum α-tocopherol in Finnish adults. Prev Med 1988;17:725-35.
36. National Center for Health Statistics. NHANES III reference manuals and reports. NCHS CD-ROM series. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention, 1996.
37. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2001;153:424-32.
38. Diabetic Retinopathy Study Group. Report number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21(1 Pt 2):210-26.
39. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care 1998;21(suppl 1):S23-31.
40. Mohadjier L, Montaquila J, Waksberg J, et al. NHNAES III weighting and estimation methodology executive summary. Rockville, MD: Westat, Inc, 1996.
41. Berglund PA. Using SAS for variance estimation with complex sample surveys. In: Proceedings of the 8th Annual Conference of the MidWest SAS Users Group. Chicago, IL: Midwest SAS Users Group, 1997:199-297.
42. Mares-Perlman JA, Brady WE, Klein R, et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-8.
43. VandenLangenberg GM, Mares-Perlman JA, Klein R, et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998;148:204-14.
44. Howard-Williams J, Patel P, Jelfs R, et al. Polyunsaturated fatty acids and diabetic retinopathy. Br J Ophthalmol 1985;69:15-18.
45. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose: implications of diagnosis of diabetes in patients examined in the afternoon. JAMA 2000;284:3157-9.